Clicky

Adverum Biotechnologies, Inc.(ADVM) News

Date Title
May 10 Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
May 10 Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
May 9 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
May 9 Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
May 3 Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
May 2 Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 25 Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Apr 23 Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
Apr 19 Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Apr 4 Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?
Apr 4 How Adverum (ADVM) Stock Stands Out in a Strong Industry
Apr 3 Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround
Mar 27 Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Mar 20 Adverum Biotechnologies Reports Encouraging Clinical Progress Amidst Financial Adjustments
Mar 19 Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
Mar 18 Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
Feb 8 Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
Feb 5 Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
Jan 29 Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
Jan 4 Here's Why You Should Invest in Adverum (ADVM) Stock Now